Parexel launches new clinical trial management system

By Melissa Fassbender contact

- Last updated on GMT

Parexel launches new clinical trial management system

Related tags: Clinical trial management, Pharmaceutical industry, Clinical trial, Pharmacology

Parexel says pharmaceutical companies could start managing their clinical trials in as little as four weeks with new system.

The US CRO claims the IMPACT Express Clinical Trial Management System (CTMS) offers a new way for small to mid-sized biopharmaceutical companies to manage clinical trials and monitoring – One of the most expensive steps in the drug development process.

“Conducting clinical trials is a complex, challenging series of tasks that involves generating and consolidating data from many sources, coordinating numerous functions, and making timely informed decisions​,” Patrick Nadolny, VP of Product Management, Data and Analytics Services, PAREXEL Informatics told

Biopharmaceuticals companies can save time and money by applying integrated processes and data driven approaches to trial management and monitoring according to Nadolny, who said the firm's new technology simplifies the process, in addition to improving patient safety oversight and regulatory compliance.

Nadolny said the platform promotes “robust clinical trial management from a single, easy-to-use implement, hosted solution​” adding that capabilitiesinclude oversight, trial tracking, site monitoring, investigator management and selection, as well as payment management.

Industry forecast

When asked what could be expected from the industry in the next five years, Nadolny said advancements in patient centric technology, which will be critical in successfully developing cost effective medicines.

We see many examples of technological devices used in academic and clinical trial settings as an exciting trend towards mHealth​,” he adds. “It is also important to note that clinical trials generate an increasing volume of data that requires new approaches to data integration and analysis​.”

According to Nadolny, drug companies will need to re-engineer their technology platform and corresponding processes to extract the right information to drive real-time decision making.

With the IMPACT Express CTMS, the company is also including a training program and expects pharmaceutical and biopharmaceutical companies to be able to start managing their clinical trials in as little as four weeks.

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 15-Aug-2022 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Related suppliers

Follow us


View more